IL104817A0 - Sugar derivatives of macrolides - Google Patents

Sugar derivatives of macrolides

Info

Publication number
IL104817A0
IL104817A0 IL104817A IL10481793A IL104817A0 IL 104817 A0 IL104817 A0 IL 104817A0 IL 104817 A IL104817 A IL 104817A IL 10481793 A IL10481793 A IL 10481793A IL 104817 A0 IL104817 A0 IL 104817A0
Authority
IL
Israel
Prior art keywords
pct
macrolides
sugar derivatives
sec
date
Prior art date
Application number
IL104817A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL104817A0 publication Critical patent/IL104817A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL104817A 1992-03-02 1993-02-22 Sugar derivatives of macrolides IL104817A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84433192A 1992-03-02 1992-03-02

Publications (1)

Publication Number Publication Date
IL104817A0 true IL104817A0 (en) 1993-06-10

Family

ID=25292419

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104817A IL104817A0 (en) 1992-03-02 1993-02-22 Sugar derivatives of macrolides

Country Status (14)

Country Link
US (1) US5747465A (xx)
EP (1) EP0629209B1 (xx)
JP (1) JP2563080B2 (xx)
AT (1) ATE153027T1 (xx)
AU (1) AU3586293A (xx)
CA (1) CA2131372C (xx)
DE (1) DE69310721T2 (xx)
DK (1) DK0629209T3 (xx)
ES (1) ES2102642T3 (xx)
FI (1) FI107535B (xx)
GR (1) GR3024048T3 (xx)
IL (1) IL104817A0 (xx)
MX (1) MX9301060A (xx)
WO (1) WO1993018050A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP584198A0 (en) 1998-09-14 1998-10-08 Fujisawa Pharmaceutical Co., Ltd. New use
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
WO2006060616A1 (en) 2004-12-01 2006-06-08 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Processes for producing crystalline macrolides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1467383A (en) * 1974-06-12 1977-03-16 Farmaceutici Italia Daunomycin analogues
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
DE3853477T2 (de) * 1987-12-09 1995-11-09 Fisons Plc Makrozyklische verbindungen.
EP0487593A1 (en) * 1989-08-18 1992-06-03 FISONS plc Macrocyclic compounds
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
EP0466365A3 (en) * 1990-07-03 1992-04-15 Merck & Co. Inc. Novel immunosuppressant fermentation products of a microorganism

Also Published As

Publication number Publication date
MX9301060A (es) 1993-09-01
FI944017A (fi) 1994-09-01
GR3024048T3 (en) 1997-10-31
EP0629209B1 (en) 1997-05-14
DE69310721T2 (de) 1997-09-04
CA2131372C (en) 1998-07-14
DE69310721D1 (de) 1997-06-19
US5747465A (en) 1998-05-05
DK0629209T3 (da) 1997-10-13
EP0629209A1 (en) 1994-12-21
AU3586293A (en) 1993-10-05
ES2102642T3 (es) 1997-08-01
JPH07500352A (ja) 1995-01-12
FI107535B (fi) 2001-08-31
WO1993018050A1 (en) 1993-09-16
FI944017A0 (fi) 1994-09-01
ATE153027T1 (de) 1997-05-15
CA2131372A1 (en) 1993-09-16
JP2563080B2 (ja) 1996-12-11

Similar Documents

Publication Publication Date Title
ZA9610543B (en) Compounds and compositions for reducing blood glucose and/or inhibiting the activity of CGRP.
CA2211612A1 (en) [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
HU9500192D0 (en) Bis-n-substituted staurosporin derivatives and pharmaceutical composition containing them and other active components
FR2696176B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
AU4774897A (en) Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage)
GR3014958T3 (en) 2,4- and 2,5-Pyridine-dicarboxylic-acid derivatives, process for their preparation, their use and medicines based on these compounds.
EP1157698A3 (en) Treatment of inflammatory diseases with oxypurine nucleosides
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
NO20005332L (no) 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding
EP0661972A4 (en) USE OF SPIPERONE OR SPIPERONE DERIVATIVES AS IMMUNODEPRESSANT AGENTS.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
IL108750A (en) Pharmaceutical cognition enhancing compositions containing 1,3-dialiphatic-8-(phenylalkyl or ludanyl) xanthines as selective adenosine receptor agents
GR3024048T3 (en) Sugar derivatives of macrolides.
AU5691796A (en) Terpenoidic derivatives useful as antitumor agents
FR2696177B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
EP0715519A4 (en) IMMUNOMODULATIVE, ANTI-INFLAMMATORY AND ANTIPROLIFERATIVE COMPOUNDS: 5,6-DIDEOXY, 5-AMINO DERIVATIVES OF IDOSE AND 6-DEOXY, 6-AMINO DERIVATIVES OF GLUCOSE
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
AU7718796A (en) 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
GB9420747D0 (en) 1,5 benzodiazepine derivatives
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
AU622521B2 (en) Pyrimidinetrione derivatives, processes for their preparation, agents containing them and their use as agents for combating pests
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
HUP0002826A3 (en) 6-azauracil derivatives, process for producing them, their use for producing medicament useful against inflammatory diseases and such compositions
AU7750794A (en) Use of hydroxychloroquine for treatment of graft-versus-host disease